FDA.reportPublic FDA data

3 ML insulin isophane, human 100 UNT/ML Pen Injector [Novolin N]

RxCUI
2206099
RxNorm name
3 ML insulin isophane, human 100 UNT/ML Pen Injector [Novolin N]
Display name
3 ML insulin isophane, human 100 UNT/ML Pen Injector [Novolin N]
Full name
3 ML insulin isophane, human 100 UNT/ML Pen Injector [Novolin N]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
019959Novolin Ninsulin isophane human351(a)OTC2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
82f1445c-b2c6-445a-82cf-ba8825fac776NovoLIN N 100 UNT/mL in 3 mL Pen Injector [PSN] · 3 ML insulin isophane, human 100 UNT/ML Pen Injector [Novolin N] [SBD] · 3 ML Novolin N 100 UNT/ML Pen Injector [SY] · Novolin N 100 UNT/ML per 3 ML Pen Injector [SY] · Relion Novolin N 100 UNT/ML per 3 ML Pen Injector [SY]517These highlights do not include all the information needed to use NOVOLIN N safely and effectively. See full prescribing information for NOVOLIN N. NOVOLIN ® N (insulin isophane human) injectable suspension, for subcutaneous use Initial U.S. Approval: 199120221123
69dffec8-6ea9-441b-b795-042dcc26843dNovoLIN N 100 UNT/mL in 3 mL Pen Injector [PSN] · 3 ML insulin isophane, human 100 UNT/ML Pen Injector [Novolin N] [SBD] · 3 ML Novolin N 100 UNT/ML Pen Injector [SY] · Novolin N 100 UNT/ML per 3 ML Pen Injector [SY] · Relion Novolin N 100 UNT/ML per 3 ML Pen Injector [SY]51These highlights do not include all the information needed to use NOVOLIN N safely and effectively. See full prescribing information for NOVOLIN N. NOVOLIN ® N (insulin isophane human) injectable suspension, for subcutaneous use Initial U.S. Approval: 199120230721